News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Advanced Global Industries Corporation Signs Merger Agreement



10/19/2005 5:12:27 PM

BELLINGHAM, Wash., Jan. 19 /PRNewswire-FirstCall/ -- Advanced Global Industries Corporation announced today that it has signed a Merger Agreement to acquire all of the issued and outstanding shares of Synova Healthcare, Inc. of Media, PA. Synova distributes non-invasive medical diagnostic tests for consumers and clinicians alike to use in order to determine the onset of specific medical conditions. The agreement calls for the issuance of 7 million shares of Advanced Global to the shareholders of Synova, and is subject to certain closing conditions.

Mr. Stephen King, CEO of Synova stated, "the signing of the merger agreement with AGBL is an important milestone for Synova. This development will allow Synova to gain access to capital markets so that we can continue to develop important new products, while effectively supporting our products that currently exist in the marketplace today. "

Mr. Randle Barrington-Foote, President of Advanced Global Industries Corporation said, "the combination of a competent management team and innovative products that Synova brings leaves us to be excited about the prospects of merging with Synova." As part of the merger, Advanced Global Industries Corporation is taking the necessary steps to change its name from Advanced Global Industries Corporation to Synova Healthcare Group, Inc.

This Press Release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy; nor will there be any sale of securities of Advanced Global Industries Corporation in any state where such offer, solicitation or sale would be unlawful before registration or qualification under the securities laws of those states.

Investor Relations: Corporate Contact: J.A. Michie, Managing Director Advanced Global Industries Corp. G.M. Capital Partners, Ltd 114 W. Magnolia Street, #446 Usteristrasse19, CH-8023 Bellingham, WA 98225 Zurich, Switzerland Tel: 800-661-7830 Tel: +41-44-226-5000 Fax: 888-639-4097 Tel: 800-647-9877 Fax: +41-44-226-5009 Email: jam@gmcapital.com

Web site:

Advanced Global Industries Corporation

CONTACT: Advanced Global Industries Corp., +800-661-7830, or fax,+888-639-4097; or investors, J.A. Michie, Managing Director of G.M. CapitalPartners, Ltd, +41-44-226-5000, or +800-647-9877, or fax, +41-44-226-5009, orjam@gmcapital.com, for Advanced Global Industries Corp.


Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES